| Vaccine-generated lung tissue–resident memory T cells provide heterosubtypic protection to influenza infection KD Zens, JK Chen, DL Farber JCI insight 1 (10), 2016 | 394 | 2016 |
| Human antibodies that bind lymphocyte activation gene-3 (lag-3) and uses thereof KB Thudium, M Selby, KD Zens, M Yamanaka, AJ Korman, HN LeBlanc US Patent App. 13/058,492, 2011 | 209 | 2011 |
| CD4+ T cell effector commitment coupled to self-renewal by asymmetric cell divisions SA Nish, KD Zens, R Kratchmarov, WHW Lin, WC Adams, YH Chen, ... Journal of Experimental Medicine 214 (1), 39-47, 2017 | 111 | 2017 |
| Memory CD4 T cells in influenza KD Zens, DL Farber Influenza pathogenesis and control-volume II, 399-421, 2014 | 111 | 2014 |
| Reduced generation of lung tissue–resident memory T cells during infancy KD Zens, JK Chen, RS Guyer, FL Wu, F Cvetkovski, M Miron, DL Farber Journal of Experimental Medicine 214 (10), 2915-2932, 2017 | 93 | 2017 |
| Three-dimensional culture conditions lead to decreased radiation induced cytotoxicity in human mammary epithelial cells MB Sowa, WB Chrisler, KD Zens, EJ Ashjian, LK Opresko Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis 687 (1 …, 2010 | 45 | 2010 |
| Human antibodies that bind CD22 and uses thereof DJ King, A Witte, HN LeBlanc, R Theolis, A Masood, M Yamanaka, ... US Patent 8,481,683, 2013 | 36 | 2013 |
| Developmental regulation of effector and resident memory T cell generation during pediatric viral respiratory tract infection TJ Connors, JS Baird, MC Yopes, KD Zens, K Pethe, TM Ravindranath, ... The Journal of Immunology 201 (2), 432-439, 2018 | 34 | 2018 |
| Human antibodies that bind lymphocyte activation gene-3 (LAG-3), and uses thereof KB Thudium, MJ Selby, KD Zens, M Yamanaka, AJ Korman, HN LeBlanc US Patent 10,344,089, 2019 | 29 | 2019 |
| Immunogenicity and safety of the tick-borne encephalitis vaccination (2009–2019): A systematic review JE Rampa, HH Askling, P Lang, KD Zens, N Gültekin, Z Stanga, ... Travel medicine and infectious disease 37, 101876, 2020 | 27 | 2020 |
| Infection and immune control of human oncogenic γ-herpesviruses in humanized mice D McHugh, N Caduff, A Murer, C Engelmann, Y Deng, H Zdimerova, ... Philosophical Transactions of the Royal Society B 374 (1773), 20180296, 2019 | 26 | 2019 |
| Analysis of Tick-borne Encephalitis vaccination coverage and compliance in adults in Switzerland, 2018 V Baroutsou, KD Zens, P Sinniger, J Fehr, P Lang Vaccine 38 (49), 7825-7833, 2020 | 23 | 2020 |
| CD27 is required for protective lytic EBV antigen–specific CD8+ T-cell expansion Y Deng, B Chatterjee, K Zens, H Zdimerova, A Müller, P Schuhmachers, ... Blood, The Journal of the American Society of Hematology 137 (23), 3225-3236, 2021 | 22 | 2021 |
| Heterogenous humoral and cellular immune responses with distinct trajectories post-SARS-CoV-2 infection in a population-based cohort D Menges, KD Zens, T Ballouz, N Caduff, D Llanas-Cornejo, ... Nature Communications 13 (1), 4855, 2022 | 21 | 2022 |
| T‐cell memory in tissues KPJM van Gisbergen, KD Zens, C Münz European journal of immunology 51 (6), 1310-1324, 2021 | 16 | 2021 |
| A microbial-based cancer vaccine for induction of EGFRvIII-specific CD8+ T cells and anti-tumor immunity L Zebertavage, S Bambina, J Shugart, A Alice, KD Zens, P Lauer, ... Plos one 14 (1), e0209153, 2019 | 16 | 2019 |
| Tissue compartmentalization of T cell responses during early life KD Zens, T Connors, DL Farber Seminars in immunopathology 39, 593-604, 2017 | 16 | 2017 |
| Human antibodies that bind lymphocyte activation gene-3 (lag-3), and uses thereof KB Thudium, MJ Selby, KD Zens, M Yamanaka, AJ Korman, HN LeBlanc US Patent App. 16/722,296, 2020 | 12 | 2020 |
| Human antibodies that bind lymphocyte activation gene-3 (lag-3), and uses thereof KB Thudium, MJ Selby, KD Zens, M Yamanaka, AJ Korman, HN LeBlanc US Patent App. 16/419,940, 2019 | 12 | 2019 |
| Retrospective, matched case–control analysis of tickborne encephalitis vaccine effectiveness by booster interval, Switzerland 2006–2020 KD Zens, SR Haile, AJ Schmidt, ES Altpeter, JS Fehr, P Lang BMJ open 12 (4), e061228, 2022 | 11 | 2022 |
Donna FarberColumbia UniversityVerified email at cumc.columbia.edu
